NCT03053388 - Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 5, 2017

Primary Completion Date

April 28, 2018

Study Completion Date

April 28, 2018

Conditions

Bronchiolitis

Interventions

DRUG

Nitric Oxide

Nitric Oxide given via inhalation in cycles

OTHER

Supportive treatment

Supportive treatment (including oxygen)

Trial Locations (10)

Haemek Medical Center, Afula

Barzili Medical Center, Ashkelon

Soroka Medical Center, Beersheba

Carmel Medical Center, Haifa

Rambam Medical Center, Haifa

Hadassah Medical Center, Jerusalem

Schneider Children's Hospital, Petah Tikva

Sheba Medical Center, Ramat Gan

Kaplan Medical Center, Rehovot

Tel-Aviv Sourasky Medical Center, Tel Aviv